French preclinical CRO NovAliX has found a new partner across the pond. Massachusetts-based manufacturer Bruker Corporation has announced a minority investment in the CRO. “This partnership with ...
Biomarker research has made substantial progress recently beyond the proverbial low-hanging fruit. Emerging technologies and techniques are helping make biomarker detection and application faster, ...
Disease modeling and target identification are critical and time-consuming portions of the drug discovery process and areas where artificial intelligence (AI) is already making a substantial impact. A ...
New mathematical tools revealing how quickly cell proteins break down are poised to uncover deeper insights into how we age, according to a recently published paper co-authored by a Mississippi State ...
Scientists have uncovered potential therapeutic avenues for metabolic diseases. "Metabolism" describes the body's chemical changes that create the necessary materials for growth and overall health.
Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery
insights from industryDr. Xiabing HanPrincipal Scientist for Antibody DiscoveryRapid Novor In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results